Logo image of ELIQ

ELECTRIQ POWER HOLDINGS INC (ELIQ) Stock Fundamental Analysis

NYSE:ELIQ - New York Stock Exchange, Inc. - US2850461086 - Common Stock - Currency: USD

0.2712  -0.02 (-6.48%)

Fundamental Rating

1

ELIQ gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 94 industry peers in the Electrical Equipment industry. Both the profitability and financial health of ELIQ have multiple concerns. ELIQ is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ELIQ was profitable.
ELIQ had a negative operating cash flow in the past year.
ELIQ Yearly Net Income VS EBIT VS OCF VS FCFELIQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 0 5M 10M 15M

1.2 Ratios

ELIQ has a better Return On Assets (1.08%) than 65.52% of its industry peers.
ELIQ has a Return On Equity of 1.30%. This is in the better half of the industry: ELIQ outperforms 64.37% of its industry peers.
Industry RankSector Rank
ROA 1.08%
ROE 1.3%
ROIC N/A
ROA(3y)5.78%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ELIQ Yearly ROA, ROE, ROICELIQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 0 5 10 15

1.3 Margins

ELIQ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ELIQ Yearly Profit, Operating, Gross MarginsELIQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

1

2. Health

2.1 Basic Checks

ELIQ has about the same amout of shares outstanding than it did 1 year ago.
ELIQ has a worse debt/assets ratio than last year.
ELIQ Yearly Shares OutstandingELIQ Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 10M 20M 30M 40M
ELIQ Yearly Total Debt VS Total AssetsELIQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of -0.21, we must say that ELIQ is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.21, ELIQ is doing worse than 62.07% of the companies in the same industry.
ELIQ has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ELIQ (0.08) is better than 64.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z -0.21
ROIC/WACCN/A
WACCN/A
ELIQ Yearly LT Debt VS Equity VS FCFELIQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 0 100M 200M 300M

2.3 Liquidity

ELIQ has a Current Ratio of 0.01. This is a bad value and indicates that ELIQ is not financially healthy enough and could expect problems in meeting its short term obligations.
ELIQ's Current ratio of 0.01 is on the low side compared to the rest of the industry. ELIQ is outperformed by 97.70% of its industry peers.
ELIQ has a Quick Ratio of 0.01. This is a bad value and indicates that ELIQ is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.01, ELIQ is doing worse than 97.70% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
ELIQ Yearly Current Assets VS Current LiabilitesELIQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2M 4M 6M 8M

More info and screens

0

3. Growth

3.1 Past

ELIQ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -96.88%.
EPS 1Y (TTM)-96.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 27.12, which means the current valuation is very expensive for ELIQ.
Based on the Price/Earnings ratio, ELIQ is valued a bit cheaper than 71.26% of the companies in the same industry.
ELIQ is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.46, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 27.12
Fwd PE N/A
ELIQ Price Earnings VS Forward Price EarningsELIQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ELIQ Per share dataELIQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ELIQ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ELECTRIQ POWER HOLDINGS INC

NYSE:ELIQ (1/16/2024, 8:19:37 PM)

0.2712

-0.02 (-6.48%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-14 2023-11-14/amc
Earnings (Next)03-20 2024-03-20/amc
Inst Owners7.56%
Inst Owner Change-0.63%
Ins Owners18.36%
Ins Owner Change0%
Market Cap11.32M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 27.12
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.16
P/tB 0.16
EV/EBITDA N/A
EPS(TTM)0.01
EY3.69%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0
BVpS1.7
TBVpS1.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.08%
ROE 1.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)5.78%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z -0.21
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-370.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-14.48%
OCF growth 3YN/A
OCF growth 5YN/A